Literature DB >> 12974481

Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators.

Jean-Christophe Renauld1.   

Abstract

Class II cytokine receptors were originally defined on the basis of sequence homologies in the extracellular domains of receptors for interferons (IFNs) and interleukin-10 (IL-10), and the ligands, known as class II cytokines, also have a common structure. More recently, a series of new receptors and cytokines that belong to this family have been discovered. The therapeutic potential of the 'old' members of this family, IFNs and IL-1, is recognized in the clinic, and the existence of structurally related molecules is raising expectations for additional clinical applications. In this review, I discuss both structural and biological data that are emerging about this family of receptors and ligands, to highlight the potential applications of modulating the activity of these cytokines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12974481     DOI: 10.1038/nri1153

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  71 in total

Review 1.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

2.  Biomechanical signals suppress proinflammatory responses in cartilage: early events in experimental antigen-induced arthritis.

Authors:  Mario Ferretti; Robert Gassner; Zheng Wang; Priyangi Perera; James Deschner; Gwendolyn Sowa; Robert B Salter; Sudha Agarwal
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

3.  Regulation of apoptosis by type III interferons.

Authors:  W Li; A Lewis-Antes; J Huang; M Balan; S V Kotenko
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

4.  The role of transposable elements in the regulation of IFN-lambda1 gene expression.

Authors:  Scott J P Thomson; Fui G Goh; Helen Banks; Thomas Krausgruber; Sergei V Kotenko; Brian M J Foxwell; Irina A Udalova
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

5.  Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies.

Authors:  Lenka S Teodorovic; Chiara Babolin; Sarah L Rowland; Sarah A Greaves; David P Baldwin; Raul M Torres; Roberta Pelanda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

Review 6.  Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.

Authors:  Ning Zhang; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Cell Biochem       Date:  2011-03-08       Impact factor: 3.396

Review 7.  Cytokine networks in neuroinflammation.

Authors:  Burkhard Becher; Sabine Spath; Joan Goverman
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

8.  Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.

Authors:  L Zhao; H Ma; Z Jiang; Y Jiang; N Ma
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

9.  Molecular modeling of the interleukin-19 receptor complex. Novel aspects of receptor recognition in the interleukin-10 cytokine family.

Authors:  Dorothee Preimel; Heinrich Sticht
Journal:  J Mol Model       Date:  2004-07-09       Impact factor: 1.810

10.  Hyperresponse to T-cell receptor signaling and apoptosis of Id1 transgenic thymocytes.

Authors:  Zengbiao Qi; Xiao-Hong Sun
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.